Do the benefits of approving a drug before confirming it works outweigh the potential costs?
monkeybusinessimages/iStock via Getty Images Plus
The FDA approved Alzheimer's disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don't yet have.
Currently, the only approved drugs for Alzheimer’s merely alleviate some of the symptoms — partially and temporarily — but do not stop the disease from progressing.
It was first officially described 115 years ago, but we still do not have a cure for Alzheimer's disease. The human brain is extremely complex, and Alzheimer’s is its most complex disease.
This antibody could be used to develop future treatments.
Orawan Pattarawimonchai/ Shutterstock
The antibody can be used to diagnose Alzheimer's disease.
The way a person with Lewy body dementia walks is different from the way a person with Alzheimer’s walks.
Having better diagnostic tools will allow healthcare professionals to provide the best care possible.
Many older people and their families worry about a diagnosis of Alzheimer’s disease.
Alzheimer's is one of the most dreaded and difficult diseases, and it has been notoriously difficult to diagnose. Could that change in the coming years with the advent of new blood tests?